These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24681545)

  • 21. Diagnosis and management of simple ovarian cysts.
    Bayar U; Barut A; Ayoğlu F
    Int J Gynaecol Obstet; 2005 Nov; 91(2):187-8. PubMed ID: 16165135
    [No Abstract]   [Full Text] [Related]  

  • 22. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovary syndrome.
    Zosmer A
    N Engl J Med; 1996 Mar; 334(10):668. PubMed ID: 8592545
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of amenorrhea.
    Aloi JA
    Compr Ther; 1995 Oct; 21(10):575-8. PubMed ID: 8565425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlations between hyperprolactinemia and galactorrhea].
    Romero Gutierrez G; Aguirre Beltran AF; Figueroa Solana MI; Malacara Hernandez JM
    Ginecol Obstet Mex; 1989 Nov; 57():294-7. PubMed ID: 2486966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
    Cagnacci A; Paoletti AM; Renzi A; Orrù M; Pilloni M; Melis GB; Volpe A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3621-5. PubMed ID: 12915645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
    Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
    Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.
    Ozdemir S; Ozdemir M; Toy H
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):358-9. PubMed ID: 18540980
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis.
    Razzi S; Luisi S; Ferretti C; Calonaci F; Gabbanini M; Mazzini M; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):188-90. PubMed ID: 16963174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen-progestagen therapy in the management of the polycystic ovary syndrome.
    Marshall JC
    J Endocrinol Invest; 1998 Oct; 21(9):618-22. PubMed ID: 9856416
    [No Abstract]   [Full Text] [Related]  

  • 37. Autonomous hyperprolactinemia in tuberous sclerosis.
    Bloomgarden ZT; McLean GW; Rabin D
    Arch Intern Med; 1981 Oct; 141(11):1513-5. PubMed ID: 7197143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactorrhea and amenorrhea with polycystic ovaries. Del Castillo syndrome or polycystic ovarian syndrome.
    Lavric MV
    Am J Obstet Gynecol; 1969 Jul; 104(6):814-7. PubMed ID: 5815671
    [No Abstract]   [Full Text] [Related]  

  • 39. Abnormalities of ovarian function.
    Macnaughton MC
    Clin Obstet Gynaecol; 1976 Apr; 3(1):181-94. PubMed ID: 1009715
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
    Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.